CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

Similar documents
CMP* (Rs) 161 Upside/ (Downside) (%) 19 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,329 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 172 Upside/ (Downside) (%) 11.6 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,414 Free Float (%) 30.3 Shares O/S (mn) 8,245

BUY NTPC. Higher Regulated Equity to Aid Profitability; Maintain BUY. Target Price: Rs192. Institutional Equity Research

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

BUY NCC. An Ordinary Quarterly Performance; Maintain BUY. Target Price: Rs98. Institutional Equity Research. 4QFY17 Result Update May 24, 2017

Nestlé India Outlook Hazy; Valuations Prohibitive

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

CMP* (Rs) 205 Upside/ (Downside) (%) 12 Bloomberg Ticker. NACO IN Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

HOLD ACC. Strong Performance on Better Volume and Firm Realizations. Target Price: Rs1,640. Institutional Equity Research

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

CMP* (Rs) 1,033 Upside/ (Downside) (%) (0.3) Bloomberg Ticker Market Cap. (Rs bn) 467 Free Float (%) 53 Shares O/S (mn) 452

CMP* (Rs) 346 Upside/ (Downside) (%) 17. Market Cap. (Rs bn) 23 Free Float (%) 42.0 Shares O/S (mn) 67

CMP (Rs) 326 Upside/ (Downside) (%) 24. Market Cap. (Rs bn) 21.7 Free Float (%) 42.0 Shares O/S (mn) 67

BUY CDSL. Strong Operating Performance; Maintain BUY. Target Price: Rs435. Institutional Equity Research. 2QFY18 Result Update October 31, 2017

CMP (Rs) 249 Upside/ (Downside) (%) Market Cap. (Rs bn) 25.5 Free Float (%) 29.7 Shares O/S (mn) 102.3

CMP* (Rs) 1,464 Upside/ (Downside) (%) 10. Market Cap. (Rs bn) 91 Free Float (%) 55 Shares O/S (mn) 62

CMP* (Rs) 237 Upside/ (Downside) (%) 29 Bloomberg Ticker. APTY IN Market Cap. (Rs bn) 136 Free Float (%) 55.9 Shares O/S (mn) 509

CMP (Rs) 702 Upside/ (Downside) (%) 42 Bloomberg Ticker. JKCE IN Market Cap. (Rs bn) 54 Free Float (%) 42 Shares O/S (mn) 77.3

BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research

CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308

KNR Constructions Robust Performance on Execution Ramp-up

CMP* (Rs) 1,424 Upside/ (Downside) (%) 19 Bloomberg Ticker Market Cap. (Rs bn) 268 Free Float (%) 46 Shares O/S (mn) 188

CMP* (Rs) 189 Upside/ (Downside) (%) (1) Bloomberg Ticker PNB IN Market Cap. (Rs bn) 402 Free Float (%) 38 Shares O/S (mn) 2,128

CMP* (Rs) 145 Upside/ (Downside) (%) 32 Bloomberg Ticker BOB IN Market Cap. (Rs bn) 384 Free Float (%) 36 Shares O/S (mn) 2,646

CMP (Rs) 133 Upside/ (Downside) (%) 35 Bloomberg Ticker. ICEM IN Market Cap. (Rs bn) 41 Free Float (%) 71.6 Shares O/S (mn) 308.1

CMP* (Rs) 289 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) 30 Free Float (%) 69 Shares O/S (mn) 105

CMP (Rs) 166 Upside/ (Downside) (%) (1) Bloomberg Ticker Market Cap. (Rs bn) 125 Free Float (%) 37 Shares O/S (mn) 726

Sonata Software HOLD. Unimpressive Show; IITS Revenue Disappoints. Institutional Equity Research. February 06, Target Price Rs190.

Aurobindo Pharma. Institutional Equity Research. Sector - Pharmaceuticals. RSec TradEdge India. March 02, 2017

CMP* (Rs) 301 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 19.6 Free Float (%) 26 Shares O/S (mn) 65

Jubilant FoodWorks. Institutional Equity Research. Sector - FMCG. RSec TradEdge India. January 17, 2017

KEC International. Recovering from a weak phase. Institutional Equity Research. Order inflow traction remains intact

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Amber Enterprises India Ltd

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

NTPC Ltd. BUY CMP (Rs.) 163 Target (Rs.) 188 Potential Upside 15% For private circulation only. Volume No.. II Issue No. 164.

BUY. NTPC Ltd Power RETAIL EQUITY RESEARCH

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Transport Corporation of India Ltd.

Transport Corporation of India Ltd.

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x

EBITDA 5,076 3, , EBITDA

Cummins India Ltd Bloomberg Code: KKC IN

TTK Prestige Ltd. Result Highlights. Revenue growth of 41% YoY, shows no slowdown yet. OPM at ~15.8%; in line with our estimate

Balkrishna Industries

Indian Oil Corporation

Ahluwalia Contracts (India)

Colgate-Palmolive (India)

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Visaka Industries Ltd

Institutional Equities

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Gillette India. Institutional Equities. 1QFY18 Result Update

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Dalmia Bharat Enterprises

Fineotex Chemical Ltd

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

NTPC Ltd. Results in line with estimates, BUY for attractive valuations. Power. EBITDA margins up at 26% (+700bps QoQ): EBITDA margins

Strides Arcolab. Inline 4Q, recent acquisitions to deepen asset growth. Institutional Equity Research. Strides Arcolab. Pharmaceuticals India

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Havells India. Q1FY18 Result Update Strong Sales growth; Margins decline. Sector: Consumer Durable CMP: ` 467. Recommendation: BUY

Colgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD

Hindustan Unilever (RHS)

Tata Steel BUY. Performance Highlights. 3QFY2010 Result Update I Steel

Colgate-Palmolive. Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,083. Recommendation: HOLD

HOLD. Coal India Ltd Coal RETAIL EQUITY RESEARCH. Uncertainty remains. GEOJIT BNP PARIBAS Research

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Simplex Infrastructures

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

ITC. 1QFY18 Result Update Higher Excise duty impacts sales; healthy EBITDA margin. Sector: FMCG CMP: ` 289. Recommendation: BUY

Need to pull up the socks. Source: Company Data; PL Research

Robust results, TLT margins improved profitability.

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

KDDL (KDDL IN) In expansion mode

Hindustan Media Ventures

Initiating Coverage. Uflex Ltd.

India Cements Rating: Target price:

TTK Prestige. Q2FY18 Result Update Healthy Sales growth; Margins expands. Sector: Consumer Durable CMP: ` 6,145. Recommendation: HOLD

Larsen & Toubro Ltd.

Indian Oil Corporation Ltd.

Apollo Hospitals Enterprise Ltd.

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Astra Microwave Products

Transcription:

3QFY18 Result Update February 05, 2018 CMP* (Rs) 166 Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245 Wage Provisioning, Lower in Plant Availability Impede Earnings Growth has delivered a weak performance in 3QFY18. Its reported PAT declined by 4.4% YoY to Rs23.6bn owing to: (1) wage provision to the tune of Rs4.5bn; and (2) lower plant availability at 83% (vs. 91.5% in 3QFY17) leading to disincentive of Rs4bn on account of shortage of coal at Mauda, Kudgi, Solapur. Looking ahead, we expect s business to improve further backed by higher capacity commercialisation, better fuel availability and likely improvement in demand owing to UDAY scheme. Rolling over our estimates to FY20E, we maintain our recommendation on the stock with a revised Target Price of Rs213 (from Rs192 earlier). Higher Revenue on Higher Generation Despite 4.0% YoY decline in average realisation to Rs3.2/unit, s net sales grew by 7.1% YoY to Rs207bn aided by 10.7% YoY rise in generation to 63.3bn units. PLF stood at 76.9% for coalbased plants and 29.9% for gas-based plants in 3QFY18, which were flat on YoY comparison. Commercialisation of 1.1GW during the quarter helped increase in regulated equity to Rs505bn. PLF incentive for the quarter stood at Rs300mn. Reported PAT down 4.4% YoY on Wage Provisioning & Lower PAF s fuel cost declined by 7.2% YoY to Rs1.9/kWh led by lower tax incidence on account of GST and decline in coal prices on account of re-grading of coal supplies. Notably, increase in interest and depreciation charge can be attributed to commercialisation of 1.1GW of assets during the quarter. Its reported PAT declined by 4.4% YoY to Rs23.6bn mainly owing to wage provisioning to the tune of Rs4.5bn (including Rs2.4bn in accelerated leave encashment offset by Rs5.6bn gain on reversal of prior-period tax and lower plant availability PAF for coal was 83% leading to disincentives of Rs4bn on account of shortage of coal at Mauda, Solapur and Kudgi. The Management remains confident of adding 4-5GW of capacity in FY19 with a capex of Rs220bn. Kudgi (800MW) and Bongaigaon (250MW) were commercialised in 3QFY18. It expects to commission 1.6GW capacity Kudgi-U3 800MW and Lara-U1 800MW and 660MW in Meja JV in 4QFY18. Outlook & Valuation Looking ahead, we expect to add commercial capacity of 5GW and 6GW in FY19E and FY20E, respectively which would lead to a significant jump in regulated equity from the current level of Rs505bn.We continue to consider as one of the best placed companies in terms of fuel security, as most of its capacity off-take will continue to be through long-term Power Purchase Agreements (PPAs). At CMP, the stock trades at P/B of 1.0x & P/E 10.1x based on FY20E, which is attractive in our view. We believe that capacity addition track record, assured RoE, robust balance-sheet and strong operational cash-flows continue to augur well for. Rolling over our estimates to FY20E, we maintain our recommendation on the stock with a revised Target Price of Rs213 (from Rs192 earlier). Share price (%) 1 mth 3 mth 12 mth Absolute performance (6.7) (8.7) (3.5) Relative to Nifty (9.7) (11.6) (26.2) Shareholding Pattern (%) Sep 17 Dec'17 Promoter 63.0 62.3 Public 37.0 37.7 1 Year Stock Price Performance 190 185 180 175 170 165 160 155 150 Feb-17 Mar-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Jan-18 Note: * CMP as on Feb. 02, 2018 Key Financials (Rs mn) FY17 FY18E FY19E FY20E Net Sales 786,853 859,989 992,101 1,119,398 Op. Profits 216,957 226,093 273,961 319,340 OPM (%) 27.6 26.3 28.5 28.5 Net Profit 90,491 96,646 114,544 135,963 YoY Gr. (%) (11.7) 6.8 18.5 18.7 EPS (Rs) 11.4 11.7 13.9 16.5 RoE (%) 9.8 9.6 10.3 11.0 ROCE (%) 8.6 7.6 8.5 9.2 EV/EBIDTA (x) 10.9 11.0 9.6 8.4 PE (x) 15.1 14.2 11.9 10.1 P/B (x) 1.4 1.3 1.2 1.0 Source: Company, RSec Research Research Analyst: Rupesh Sankhe Contact: (022) 3320 1606 Email: rupesh.sankhe@relianceada.com 1

Risks to the View ff ff Any significant delay in project execution. Lower coal availability. Exhibit 1: Quarterly Performance (Rs mn) 3QFY18 3QFY17 YoY (%) 2QFY18 QoQ (%) 9HFY18 9HFY17 YoY (%) Net Sales 207,744 193,959 7.1 196,988 5.5 603,524 578,568 4.3 Operating Costs 154,974 141,440 9.6 142,585 8.7 445,951 420,353 6.1 EBIDTA 52,770 52,519 0.5 54,402 (3.0) 157,573 158,215 (0.4) EBIDTA Margin (%) 25.4 27.1 (1.7) 27.6 26.1 27.3 Other Income 3,135 2,502 25.3 2,616 19.8 12,377 5,987 106.7 Interest 10,650 9,090 17.2 9,195 15.8 28801 26993 6.7 Depreciation 18,814 14,853 26.7 17,127 9.8 51,641 43,147 19.7 Profit Before Tax 26,441 31,077 (14.9) 30,697 (13.9) 89,509 94,063 (4.8) Tax 2,240 6,133 (63.5) 7,842 (71.4) 18,554 20,741 Tax Rate (%) 8.5 19.7 25.5 20.7 22.1 Regulatory expenses (593.1) (252.0) - 1530.80-3220.4 (263.2) - Adj. PAT 23,608 24,693 (4.4) 24,386 (3.2) 74,176 73,059 1.5 Source: Company, RSec Research 2

Profit & Loss Statement (Rs mn) FY17 FY18E FY19E FY20E Revenues 786,853 859,989 992,101 1,119,398 Growth (%) 11.6 9.3 15.4 12.8 Operating Profit 216,957 226,093 273,961 319,340 Other Income 6,570 2,628 2,812 3,009 EBIDTA 223,526 228,721 276,772 322,349 Growth (%) 19.4 2.3 21.0 16.5 Depreciation & Amortisation 59,208 67,577 78,158 84,999 EBIT 164,318 161,143 198,614 237,349 Interest Charges (Net) 35,972 38,807 51,763 56,065 PBT (Before E/o items) 128,346 122,336 146,851 181,284 Tax provision 30,026 25,690 32,307 45,321 Minority interest 7,830 - - - Pre-exceptional PAT 90,491 96,646 114,544 135,963 Extra-ordinary items 3,357 - - - Net Profit 93,848 96,646 114,544 135,963 Growth (%) (8.4) 3.0 18.5 18.7 EPS (Rs) 11.4 11.7 13.9 16.5 Balance Sheet BALANCE SHEET FY17 FY18E FY19E FY20E Equity Share Capital 82,455 82,455 82,455 82,455 Reserves & Surplus 879,858 976,504 1,091,047 1,227,011 Shareholders' Funds 962,313 1,058,959 1,173,502 1,309,466 Total Debt 1,025,870 1,155,719 1,280,361 1,344,714 Deferred Tax liability 15,600 15,600 15,600 15,600 Capital Employed 2,003,783 2,230,278 2,469,464 2,669,780 Fixed Assets 1,800,927 2,028,917 2,250,759 2,385,759 Cash & cash eq. 29,304 26,506 32,359 23,338 Net current assets 84,027 91,923 88,910 100,361 Investments 89,524 82,932 97,436 160,322 Total Assets 2,003,783 2,230,278 2,469,464 2,669,780 3

Cash Flow Statement Y/E Mar (Rs mn) FY17 FY18E FY19E FY20E Pre-tax profit 128,346 122,336 146,851 181,284 Depreciation 59,208 67,577 78,158 84,999 Total tax paid (30,026) (25,690) (32,307) (45,321) Chg in working capital 21,746 (7,895) 3,013 (11,451) Other items (4,472) - - - Cash from oper. (a) 174,802 156,328 195,715 209,512 Capital expenditure (279,501) (295,567) (300,000) (220,000) Chg in investments (6,592) 6,592 (14,505) (62,886) Cash from inv. (b) (286,094) (288,975) (314,505) (282,886) Free cash flow (a+b) (111,291) (132,647) (118,789) (73,374) Cash from fin. (c) 96,531 129,849 124,643 64,352 Net chg in cash (a+b+c) (14,760) (2,798) 5,853 (9,022) Closing Cash balance 29,304 26,506 32,359 23,338 Key Ratios Y/E Mar FY17 FY18E FY19E FY20E OPM (%) 27.6 26.3 27.6 28.5 Net Margin (%) 11.5 11.2 11.5 12.1 Dividend Yield (%) 1.6 1.6 1.9 2.3 Net Debt/Equity (x) 1.0 1.1 1.1 1.0 ROACE (%) 8.6 7.6 8.5 9.2 ROANW (%) 9.8 9.6 10.3 11.0 EV/Sales (x) 3.0 2.9 2.6 2.4 EV/EBIDTA (x) 10.9 11.0 9.6 8.4 PE x) 15.1 14.2 11.9 10.1 P/B (x) 1.4 1.3 1.2 1.0 4

Rating Guides Rating Expected absolute returns (%) over 12 months >10% HOLD -5% to 10% REDUCE >-5% Reliance Securities Limited (RSL), the broking arm of Reliance Capital is one of the India s leading retail broking houses. Reliance Capital is amongst India s leading and most valuable financial services companies in the private sector. Reliance Capital has interests in asset management and mutual funds, life and general insurance, commercial finance, equities and commodities broking, wealth management services, distribution of financial products, private equity, asset reconstruction, proprietary investments and other activities in financial services. The list of associates of RSL is available on the website www.reliancecapital.co.in. RSL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014 General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by RSL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or offering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, affiliates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, affiliates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely affected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces affecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be affected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may affect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/ or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. None of RSL, research analysts, or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. RSL s Associates may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report. RSL, its Associates, the research analysts, or their relatives might have financial interest in the issuer company(ies) of the said securities. RSL or its Associates may have received a compensation from the said issuer company(ies) in last 12 months for the brokerage or non brokerage services.rsl, its Associates, the research analysts or their relatives have not received any compensation or other benefits directly or indirectly from the said issuer company(ies) or any third party in last 12 months in any respect whatsoever for preparation of this report. The research analysts has served as an officer, director or employee of the said issuer company(ies)?: No RSL, its Associates, the research analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies).?: No Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. RSL s activities were neither suspended nor have defaulted with any stock exchange with whom RSL is registered. Further, there does not exist any material adverse order/judgments/ strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against RSL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. RSL CIN: U65990MH2005PLC154052. SEBI registration no. ( Stock Brokers: NSE - INB / INF / INE 231234833; BSE - INB / INF / INE 011234839, Depository Participants: CDSL IN-DP-257-2016 IN-DP-NSDL-363-2013, Research Analyst: INH000002384); AMFI ARN No.29889. 5